State-Mandated Opioid Use Disorder Treatment In Maryland Jails Helped Patients Recover Despite Gaps In Care

Providing medications for opioid use disorder (MOUD) reduces overdose risk after release from a carceral facility. In 2019, Maryland enacted a comprehensive law mandating that all jails provide all three forms of MOUD during incarceration and reentry support. The experiences of patients who received this care in jail have not been explored to date. We examined the perspectives of twenty-four people recently released from Maryland jails during the period January 2023-March 2024. Most participants noted an improvement in opioid addiction care in jail when compared with their previous jail stays. They praised jail-based MOUD and believed that receiving MOUD in custody helped reduce the risk for return to use, recidivism, and overdose death. However, participants described challenges in receiving timely care that led them to experience withdrawal in jail and ongoing stigma from jail staff. Addiction counseling in jail was desired but not always available. As more states seek to expand MOUD in jails, Maryland's experience provides a promising model but also reveals ongoing implementation challenges.

Authors

Institutions

Publication Details

Journal
Health Affairs
Published
2025-05-01
DOI
https://doi.org/10.1377/hlthaff.2024.01423
Citations
2
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
3.76
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

State-Mandated Opioid Use Disorder Treatment In Maryland Jails Helped Patients Recover Despite Gaps In Care

Alene Kennedy‐Hendricks, Brendan K. Saloner, Carolyn Sufrin, Sachini Bandara et al.
2 citations
Health Affairs
Opioid Use Disorder Treatment
3.76
article

State-Mandated Opioid Use Disorder Treatment In Maryland Jails Helped Patients Recover Despite Gaps In Care

Alene Kennedy‐Hendricks, Brendan K. Saloner, Carolyn Sufrin, Sachini Bandara, Camille T. Kramer, Claudia Lenz, Michael Fingerhood, Minna Song
article en
2 citations

Abstract

Providing medications for opioid use disorder (MOUD) reduces overdose risk after release from a carceral facility. In 2019, Maryland enacted a comprehensive law mandating that all jails provide all three forms of MOUD during incarceration and reentry support. The experiences of patients who received this care in jail have not been explored to date. We examined the perspectives of twenty-four people recently released from Maryland jails during the period January 2023-March 2024. Most participants noted an improvement in opioid addiction care in jail when compared with their previous jail stays. They praised jail-based MOUD and believed that receiving MOUD in custody helped reduce the risk for return to use, recidivism, and overdose death. However, participants described challenges in receiving timely care that led them to experience withdrawal in jail and ongoing stigma from jail staff. Addiction counseling in jail was desired but not always available. As more states seek to expand MOUD in jails, Maryland's experience provides a promising model but also reveals ongoing implementation challenges.

Health AffairsVol. 44(5)
Johns Hopkins University (US), Johns Hopkins Medicine (US), Johns Hopkins University Applied Physics Laboratory (US)
Good health and well-being
Openalex Percentile: Top 8%
Opioid Use Disorder Treatment
3.76
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.